Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade
Hypha Labs (OTCQB:FUNI), a functional mushroom sciences company, has announced two significant technological acquisitions: a new High-Performance Liquid Chromatography (HPLC) analytic machine and early access to Lucidity Systems' variable loop autosampler upgrade. The new equipment will enhance the company's ability to conduct precise measurements and analysis of MicroPearls™ products.
The technological upgrades will enable Hypha Labs to achieve higher potency resolution, more effective peak separation, and unprecedented accuracy in measuring Micropearl active compounds. This advancement is expected to improve research capabilities with their Mushroom Accelerator machine and lead to more consistent product outcomes.
Hypha Labs (OTCQB:FUNI), un'azienda specializzata nelle scienze dei funghi funzionali, ha annunciato due importanti acquisizioni tecnologiche: una nuova macchina analitica a Cromatografia Liquida ad Alte Prestazioni (HPLC) e l'accesso anticipato all'aggiornamento del campionatore automatico a loop variabile di Lucidity Systems. Queste nuove attrezzature miglioreranno la capacità dell'azienda di effettuare misurazioni precise e analisi dei prodotti MicroPearls™.
Gli aggiornamenti tecnologici permetteranno a Hypha Labs di ottenere una risoluzione di potenza superiore, una separazione più efficace dei picchi e un'accuratezza senza precedenti nella misurazione dei composti attivi delle MicroPearl. Questo progresso è destinato a potenziare le capacità di ricerca con la loro macchina Mushroom Accelerator e a garantire risultati di prodotto più coerenti.
Hypha Labs (OTCQB:FUNI), una empresa especializada en ciencias de hongos funcionales, ha anunciado dos adquisiciones tecnológicas importantes: una nueva máquina analítica de Cromatografía Líquida de Alta Resolución (HPLC) y acceso anticipado a la actualización del muestreador automático de bucle variable de Lucidity Systems. Este nuevo equipo mejorará la capacidad de la empresa para realizar mediciones precisas y análisis de los productos MicroPearls™.
Las mejoras tecnológicas permitirán a Hypha Labs alcanzar una mayor resolución de potencia, una separación más efectiva de picos y una precisión sin precedentes en la medición de los compuestos activos de MicroPearl. Este avance se espera que mejore las capacidades de investigación con su máquina Mushroom Accelerator y conduzca a resultados de producto más consistentes.
Hypha Labs (OTCQB:FUNI)는 기능성 버섯 과학 회사로서, 두 가지 중요한 기술적 인수를 발표했습니다: 새로운 고성능 액체 크로마토그래피(HPLC) 분석 기계와 Lucidity Systems의 가변 루프 자동 시료 채취기 업그레이드 조기 접근권입니다. 이 새로운 장비는 회사가 MicroPearls™ 제품의 정밀한 측정 및 분석 능력을 향상시킬 것입니다.
기술 업그레이드를 통해 Hypha Labs는 더 높은 효능 해상도, 더욱 효과적인 피크 분리, 그리고 MicroPearl 활성 화합물 측정에서 전례 없는 정확성을 달성할 수 있게 됩니다. 이 발전은 Mushroom Accelerator 기계와 함께 연구 능력을 향상시키고 제품 결과의 일관성을 높일 것으로 기대됩니다.
Hypha Labs (OTCQB:FUNI), une entreprise spécialisée dans les sciences des champignons fonctionnels, a annoncé deux acquisitions technologiques majeures : une nouvelle machine analytique de chromatographie liquide haute performance (HPLC) et un accès anticipé à la mise à niveau de l'automate à boucle variable de Lucidity Systems. Ce nouvel équipement améliorera la capacité de l'entreprise à réaliser des mesures précises et des analyses des produits MicroPearls™.
Les améliorations technologiques permettront à Hypha Labs d'obtenir une résolution de puissance plus élevée, une séparation des pics plus efficace et une précision sans précédent dans la mesure des composés actifs des MicroPearls. Cette avancée devrait renforcer les capacités de recherche avec leur machine Mushroom Accelerator et conduire à des résultats produits plus cohérents.
Hypha Labs (OTCQB:FUNI), ein Unternehmen für funktionelle Pilzwissenschaften, hat zwei bedeutende technologische Anschaffungen bekannt gegeben: ein neues Hochleistungs-Flüssigkeitschromatographie-(HPLC)-Analysegerät und einen frühen Zugang zum Upgrade des variablen Loop-Autosamplers von Lucidity Systems. Die neue Ausrüstung wird die Fähigkeit des Unternehmens verbessern, präzise Messungen und Analysen der MicroPearls™-Produkte durchzuführen.
Die technologischen Upgrades ermöglichen es Hypha Labs, eine höhere Potenzauflösung, effektivere Peak-Trennung und eine beispiellose Genauigkeit bei der Messung der aktiven MicroPearl-Verbindungen zu erreichen. Dieser Fortschritt wird voraussichtlich die Forschungskapazitäten mit ihrer Mushroom Accelerator-Maschine verbessern und zu konsistenteren Produktergebnissen führen.
- Acquisition of advanced HPLC machine enhances analytical capabilities
- Early access partnership with Lucidity Systems for autosampler upgrade
- Improved measurement accuracy and potency resolution
- Enhanced ability to produce more consistent products
- None.
LAS VEGAS, NV / ACCESS Newswire / May 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the acquisition of a cutting-edge High-Performance Liquid Chromatography (HPLC) analytic machine, further enhancing our capabilities in precision measurement and analysis. In a strategic partnership with Lucidity Systems, the Company is also thrilled to announce early access to their newly released variable loop autosampler upgrade, designed to elevate the performance of its already advanced machine.
This collaboration allows Hypha Labs to leverage Lucidity Systems' innovative technology, enabling the Company to exercise its advanced methods and techniques at a higher potency resolution. The new autosampler upgrade will significantly enhance the Company's ability to conduct low granular resolution measurements, which is crucial for its ongoing research and development efforts.
With this upgrade, Hyph Labs will be able to separate peaks more effectively and measure the potencies of the Micropearl active compounds with unprecedented accuracy. This advancement will provide the Company with deeper insights, allowing Hypha Labs to fine tune its research more precisely with the revolutionary Mushroom Accelerator machine. This is a win for customers, allowing the Company to produce a more consistent and highly valued product outcome.
"We are thrilled to partner with Lucidity Systems and gain early access to their latest ground-breaking technology," said John Frailey, CTO at Hypha Labs. "This upgrade will not only enhance our analytical capabilities but also empower us to push the boundaries of our research in the field of mycology."
Hypha Labs remains committed to advancing the science of mushroom cultivation equipment and genetic research to accommodate these advances. The integration of this new HPLC machine and the variable loop autosampler upgrade marks a significant milestone in Hypha's journey to deliver innovative solutions and insights to our customers, clients and partners.
Please add Hypha Labs to your Stockhouse "Watchlist" here:
https://stockhouse.com/companies/quote?symbol=funi
Join the Company's Stockhouse bullboard here:
https://stockhouse.com/companies/bullboard?symbol=funi
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise. Hypha Labs has paid Stockhouse
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity Media Inc.
(888) 216-3595
team@integritymedia.com
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire
FAQ
What new equipment did Hypha Labs (FUNI) acquire in May 2025?
How will the new HPLC machine benefit Hypha Labs' operations?
What is the purpose of the Lucidity Systems autosampler upgrade for FUNI?
How will these technological upgrades impact Hypha Labs' products?
